Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring 
RALEIGH, N.C., May 31, 2017 -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief Executive Officer Alistair Macdonald is scheduled to present at the 2017 Jefferies Global Healthcare Conference in New York, NY. Mr. Macdonald’s presentation is scheduled for Wednesday, June 7, 2017, at 11 a.m. EDT.
Links to INC Research’s live presentation and archived audio replay, as well as the presentation materials, will be available via the Company’s Investor Relations website at investor.incresearch.com.
About INC Research
INC Research (Nasdaq:INCR) is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was ranked “Top CRO to Work With” among the top 10 global CROs in the 2017 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 110 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.
Investor Relations Contact: Ronnie Speight Vice President, Investor Relations Phone: +1 (919) 745-2745 Email: [email protected] Press/Media Contact: Lori Dorer Senior Director, Corporate Communications Phone: +1 (919) 745-2890 Email: [email protected]
